TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery
Brief Summary: The risk of urinary tract infection (UTI) following female incontinence surgery ranges between 6-48%. The literature has shown mixed results of the therapeutic efficacy of cranberry extract to prevent UTI in females, with some promising preliminary work in the prevention of UTI's following gynecologic surgery. The researchers will conduct a study of the effect of cranberry extracts on preventing urinary tract infections following mid urethral slings, which are the most common urinary incontinence procedures.


Options:
A: Arm Label: BMI <30; Type: N/A; Interventions: N/A | Arm Label: BMI 30-39; Type: N/A; Interventions: N/A | Arm Label: BMI >40; Type: N/A; Interventions: N/A
B: Arm Label: Ajust sling; Type: EXPERIMENTAL; Interventions: Procedure: Ajust system, Procedure: TVT/TVT-O | Arm Label: TVT/TVT-O, polypropylne slings; Type: EXPERIMENTAL; Interventions: Procedure: Ajust system, Procedure: TVT/TVT-O | Intervention Type: PROCEDURE; Name: Ajust system; Assigned to Arm(s): Ajust sling, TVT/TVT-O, polypropylne slings | Intervention Type: PROCEDURE; Name: TVT/TVT-O; Assigned to Arm(s): Ajust sling, TVT/TVT-O, polypropylne slings
C: Arm Label: Cranberry Extract Capsules; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cranberry extract capsules | Arm Label: Placebo Capsules; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsule | Intervention Type: DIETARY_SUPPLEMENT; Name: Cranberry extract capsules; Assigned to Arm(s): Cranberry Extract Capsules | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsule; Assigned to Arm(s): Placebo Capsules
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Drug: Nitrofurantoin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Nitrofurantoin; Assigned to Arm(s): Treatment | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Brief Summary: The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).


Options:
A: Arm Label: Dupilumab; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 4 Milligram (mg) Baricitinib; Type: EXPERIMENTAL; Interventions: Drug: Baricitinib, Drug: Placebo | Arm Label: 2 mg Baricitinib; Type: EXPERIMENTAL; Interventions: Drug: Baricitinib, Drug: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 4 mg Baricitinib Maximum Extended Enrollment (MEE); Type: EXPERIMENTAL; Interventions: Drug: Baricitinib, Drug: Placebo | Arm Label: 2 mg Baricitinib MEE; Type: EXPERIMENTAL; Interventions: Drug: Baricitinib | Arm Label: Placebo MEE; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Baricitinib; Assigned to Arm(s): 2 mg Baricitinib, 2 mg Baricitinib MEE, 4 Milligram (mg) Baricitinib, 4 mg Baricitinib Maximum Extended Enrollment (MEE) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 mg Baricitinib, 4 Milligram (mg) Baricitinib, 4 mg Baricitinib Maximum Extended Enrollment (MEE), Placebo, Placebo MEE
C: Arm Label: Phototherapeutic; Type: EXPERIMENTAL; Interventions: Radiation: ultraviolet A (UVA) | Arm Label: Conventional therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone Acetonide | Intervention Type: RADIATION; Name: ultraviolet A (UVA); Assigned to Arm(s): Phototherapeutic | Intervention Type: DRUG; Name: Triamcinolone Acetonide; Assigned to Arm(s): Conventional therapy
D: Arm Label: Hydrocortisone 1%; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone 1% | Arm Label: Clobetasol Propionate 0.05%; Type: EXPERIMENTAL; Interventions: Drug: Clobetasol Propionate 0.05% | Intervention Type: DRUG; Name: Hydrocortisone 1%; Assigned to Arm(s): Hydrocortisone 1% | Intervention Type: DRUG; Name: Clobetasol Propionate 0.05%; Assigned to Arm(s): Clobetasol Propionate 0.05%

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of the Use of a Polyurethane Foam Multilayer Dressing in the Sacral Area, in Addition to Standard Healthcare, to Prevent the Onset of Pressure Ulcer in Patients at Risk. Multicentric Randomized Controlled Trial
Brief Summary: The aim of the present study was to assess whether the application of a multilayered dressing made of hydrocellular polyurethane foam conformed to the sacral area (MSP) in addition to standard preventive care reduces the rate of pressure ulcer (PU) and their severity in population at risk admitted in acute care Hospital.


Options:
A: Arm Label: skin care arm of where evidence-based practices in the implementation guide; Type: EXPERIMENTAL; Interventions: Other: skin care arm of where evidence-based practices in the implementation guide | Arm Label: hydrocolloid (Convatec Granuflex-extra thin) dressing; Type: EXPERIMENTAL; Interventions: Device: hydrocolloid (Convatec Granuflex-extra thin) dressing | Arm Label: control; Type: OTHER; Interventions: Other: control | Intervention Type: OTHER; Name: skin care arm of where evidence-based practices in the implementation guide; Assigned to Arm(s): skin care arm of where evidence-based practices in the implementation guide | Intervention Type: DEVICE; Name: hydrocolloid (Convatec Granuflex-extra thin) dressing; Assigned to Arm(s): hydrocolloid (Convatec Granuflex-extra thin) dressing | Intervention Type: OTHER; Name: control; Assigned to Arm(s): control
B: Arm Label: Hyper-oxigenated fatty acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hyper-oxigenated fatty acid | Arm Label: Olive oil's Cream; Type: EXPERIMENTAL; Interventions: Other: Olive oil's cream | Intervention Type: DRUG; Name: Hyper-oxigenated fatty acid; Assigned to Arm(s): Hyper-oxigenated fatty acid | Intervention Type: OTHER; Name: Olive oil's cream; Assigned to Arm(s): Olive oil's Cream
C: Arm Label: Mepilex® Border; Type: EXPERIMENTAL; Interventions: Device: Mepilex® Border Sacrum and Mepilex® Border Heel | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Mepilex® Border Sacrum and Mepilex® Border Heel; Assigned to Arm(s): Mepilex® Border
D: Arm Label: Hydrocellular polyurethane foam multilayer dressing; Type: EXPERIMENTAL; Interventions: Device: Hydrocellular polyurethane foam multilayer dressing, Procedure: Standard preventive care | Arm Label: standard preventive care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard preventive care | Intervention Type: DEVICE; Name: Hydrocellular polyurethane foam multilayer dressing; Assigned to Arm(s): Hydrocellular polyurethane foam multilayer dressing | Intervention Type: PROCEDURE; Name: Standard preventive care; Assigned to Arm(s): Hydrocellular polyurethane foam multilayer dressing, standard preventive care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Post-partum Non-pharmacologic Pain Management
Brief Summary: This study aims to examine whether use of an abdominal binder for postpartum patients after vaginal delivery can effectively manage their pain and reduce the need for pharmacologic analgesics. The investigators hypothesize that use of an abdominal binder will decrease patient pain as reported on a visual analog scale of one to ten, and will decrease quantity of pain medications given. The study will be conducted at the Berry Women's Center at Miami Valley Hospital. Potential eligible participants will be approached regarding the study on admission to labor and delivery. The investigators will recruit 130 participants that will be randomized to two study arms, standard care and standard care plus abdominal binder with 65 participants in each study arm. Data will be collected prospectively while participants are admitted, and through review of electronic medical records. Potential benefits of this study include investigation of a cost-effective method for pain management that could improve patient comfort and reduce need for medications.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo oral capsule, Drug: Paracetamol | Arm Label: Ginger; Type: EXPERIMENTAL; Interventions: Drug: Ginger, Drug: Paracetamol | Arm Label: Paracetamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paracetamol | Intervention Type: DRUG; Name: Ginger; Assigned to Arm(s): Ginger | Intervention Type: DRUG; Name: Placebo oral capsule; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Ginger, Paracetamol, Placebo
B: Arm Label: Lifestyle Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Balance after Baby Lifestyle Intervention Program | Arm Label: Post-gestational diabetes mellitus (GDM) Follow-up Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Balance after Baby Lifestyle Intervention Program; Assigned to Arm(s): Lifestyle Intervention group
C: Arm Label: Post-partum primi and multiparous women; Type: EXPERIMENTAL; Interventions: Device: Leboride | Arm Label: Post-partum women that have already begun breast feeding; Type: EXPERIMENTAL; Interventions: Device: Leboride | Intervention Type: DEVICE; Name: Leboride; Assigned to Arm(s): Post-partum primi and multiparous women, Post-partum women that have already begun breast feeding
D: Arm Label: Binder Arm; Type: EXPERIMENTAL; Interventions: Device: Abdominal binder | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Abdominal binder; Assigned to Arm(s): Binder Arm

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Effectiveness of a Self-applied Online Program to Promote Resilience and Coping Skills in University Students in Three Spanish-speaking Countries: Study Protocol for a Randomized Controlled Trial
Brief Summary: This study aims to evaluate the effectiveness and efficiency of this intervention protocol applied to three populations of Spanish-speaking university students (Spain, Argentina and Mexico). The purpose of this paper is to present the protocol designed to carry out the randomised controlled study (RCT).


Options:
A: Arm Label: Mindful Response to Adversity; Type: EXPERIMENTAL; Interventions: Behavioral: Mindful response to adversity brief training | Arm Label: Strength-based approach to adversity; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Strengths-based response to adversity brief training | Intervention Type: BEHAVIORAL; Name: Mindful response to adversity brief training; Assigned to Arm(s): Mindful Response to Adversity | Intervention Type: BEHAVIORAL; Name: Strengths-based response to adversity brief training; Assigned to Arm(s): Strength-based approach to adversity
B: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
C: Arm Label: Mental Training for Surgeons; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Based Stress Reduction - modified | Arm Label: The Mind of a Surgeon; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active listening and reading | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction - modified; Assigned to Arm(s): Mental Training for Surgeons | Intervention Type: BEHAVIORAL; Name: Active listening and reading; Assigned to Arm(s): The Mind of a Surgeon
D: Arm Label: CORE condition; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Healthy lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy lifestyle | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): CORE condition | Intervention Type: BEHAVIORAL; Name: Healthy lifestyle; Assigned to Arm(s): Healthy lifestyle

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Effectiveness of a Self-applied Online Program to Promote Resilience and Coping Skills in University Students in Three Spanish-speaking Countries: Study Protocol for a Randomized Controlled Trial
Brief Summary: This study aims to evaluate the effectiveness and efficiency of this intervention protocol applied to three populations of Spanish-speaking university students (Spain, Argentina and Mexico). The purpose of this paper is to present the protocol designed to carry out the randomised controlled study (RCT).


Options:
A: Arm Label: CORE condition; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Healthy lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy lifestyle | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): CORE condition | Intervention Type: BEHAVIORAL; Name: Healthy lifestyle; Assigned to Arm(s): Healthy lifestyle
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: yoga, Behavioral: cognitive therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive therapy, Behavioral: wellness | Intervention Type: BEHAVIORAL; Name: yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: cognitive therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: wellness; Assigned to Arm(s): 2
C: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Behavioral: Acceptance Therapy (ACT) | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Other: Cognitive Behavioral Therapy (CBT) | Intervention Type: BEHAVIORAL; Name: Acceptance Therapy (ACT); Assigned to Arm(s): ACT | Intervention Type: OTHER; Name: Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): CBT
D: Arm Label: Intervention group 4s (mindfulness); Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness and Mindful Self-Compassion | Arm Label: Intervention group 8s (mindfulness); Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness and Mindful Self-Compassion | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness and Mindful Self-Compassion; Assigned to Arm(s): Intervention group 4s (mindfulness), Intervention group 8s (mindfulness)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Effectiveness of a Self-applied Online Program to Promote Resilience and Coping Skills in University Students in Three Spanish-speaking Countries: Study Protocol for a Randomized Controlled Trial
Brief Summary: This study aims to evaluate the effectiveness and efficiency of this intervention protocol applied to three populations of Spanish-speaking university students (Spain, Argentina and Mexico). The purpose of this paper is to present the protocol designed to carry out the randomised controlled study (RCT).


Options:
A: Arm Label: CORE condition; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Healthy lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy lifestyle | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): CORE condition | Intervention Type: BEHAVIORAL; Name: Healthy lifestyle; Assigned to Arm(s): Healthy lifestyle
B: Arm Label: MBT therapy plus treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Mentalization-Based Group Therapy for Adolescents | Arm Label: Treatment as usual alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mentalization-Based Group Therapy for Adolescents; Assigned to Arm(s): MBT therapy plus treatment as usual
C: Arm Label: Inpatient Adaptation of DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Inpatient Adaptation of DBT | Arm Label: Outpatient DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: standard outpatient DBT | Intervention Type: BEHAVIORAL; Name: standard outpatient DBT; Assigned to Arm(s): Outpatient DBT | Intervention Type: BEHAVIORAL; Name: Inpatient Adaptation of DBT; Assigned to Arm(s): Inpatient Adaptation of DBT
D: Arm Label: TFP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Transference-Focused Psychotherapy | Arm Label: ECP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: treatment by experienced community psychotherapists | Intervention Type: BEHAVIORAL; Name: Transference-Focused Psychotherapy; Assigned to Arm(s): TFP | Intervention Type: BEHAVIORAL; Name: treatment by experienced community psychotherapists; Assigned to Arm(s): ECP

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo Transfer
Brief Summary: Uterine contraction has a negative impact on implantation and pregnancy rates. Inhibition of oxytocin receptors decreases uterine contraction frequency both on pregnant and non-pregnant women. Atosiban has been studied as an oxytocin antagonist to decrease uterine contraction frequency in order to increase implantation and pregnancy rates in assisted reproduction. Previous studies have studied 37,5mg total dose which was used both before and during embryo transfer, and found atosiban to be effective in increasing implantation and pregnancy rates. We aim to use a single dose of 6,75mg atosiban before embryo transfer, in order to decrease the dose and cost and possibly introduce a simpler protocol. Our study will also be the first randomized clinical study which investigates the effect of atosiban on frozen-thawed embryo transfer cycles.


Options:
A: Arm Label: Nolasiban 900 mg; Type: EXPERIMENTAL; Interventions: Drug: Nolasiban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nolasiban; Assigned to Arm(s): Nolasiban 900 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Atosiban used before embryo transfer; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban used before embryo transfer
C: Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Placebo
D: Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo Transfer
Brief Summary: Uterine contraction has a negative impact on implantation and pregnancy rates. Inhibition of oxytocin receptors decreases uterine contraction frequency both on pregnant and non-pregnant women. Atosiban has been studied as an oxytocin antagonist to decrease uterine contraction frequency in order to increase implantation and pregnancy rates in assisted reproduction. Previous studies have studied 37,5mg total dose which was used both before and during embryo transfer, and found atosiban to be effective in increasing implantation and pregnancy rates. We aim to use a single dose of 6,75mg atosiban before embryo transfer, in order to decrease the dose and cost and possibly introduce a simpler protocol. Our study will also be the first randomized clinical study which investigates the effect of atosiban on frozen-thawed embryo transfer cycles.


Options:
A: Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Metformin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin, Placebo
C: Arm Label: atosiban; Type: EXPERIMENTAL; Interventions: Drug: atosiban | Arm Label: 0.9% salain; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% saline | Intervention Type: DRUG; Name: atosiban; Assigned to Arm(s): atosiban | Intervention Type: DRUG; Name: 0.9% saline; Assigned to Arm(s): 0.9% salain
D: Arm Label: Atosiban used before embryo transfer; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban used before embryo transfer

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Integrated Care Pathway for Hip Fractures in a Subacute Rehabilitation Setting
Brief Summary: The effectiveness of integrated care pathways for hip fractures in sub-acute rehabilitation settings is not known. The study objective was to assess if a hip fracture integrated care pathway at a sub-acute rehabilitation facility would result in better functional outcomes, shorter length of stay and fewer institutionalisations. A randomised controlled trial on an integrated care pathway was conducted for hip fracture patients in a sub-acute rehabilitation setting. The study supports the use of integrated care pathways in sub-acute rehabilitation settings to reduce length of stay whilst achieving the same functional gains.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Care Pathway | Intervention Type: OTHER; Name: Care Pathway; Assigned to Arm(s): Intervention group
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary intervention program | Intervention Type: OTHER; Name: Interdisciplinary intervention program; Assigned to Arm(s): Experimental group
C: Arm Label: GFC: Geriatric Fracture Center; Type: N/A; Interventions: N/A | Arm Label: UCC: Usual Care Center; Type: N/A; Interventions: N/A
D: Arm Label: Care pathway teams.; Type: EXPERIMENTAL; Interventions: Behavioral: Care pathway. | Arm Label: Usual care teams.; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Care pathway.; Assigned to Arm(s): Care pathway teams.

Answer: A